Rhythm Pharmaceuticals, Inc.
RYTM NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 4, 2026
ET
EPS Est.
-0.81
EPS Actual
-0.73
Revenue Est.
$67.7M
Revenue Actual
$71.3M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
Your time zone matches ET
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.72
Revenue Est.
$83.9M
Company Overview
Rhythm Pharmaceuticals, Inc. (ticker RYTM) is listed on NASDAQ with a market cap of about $7.55B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), Pre-market, with consensus EPS of -0.72. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Mar 1, 2023 → Aug 4, 2026
Mar 1, 2023Range: -2.35 ~ -0.55Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -0.81 | -0.73 | $67.7M | $71.3M |
| May 5, 2026 | -- | -0.86 | -0.83 | $55.8M | $60.1M |
| Feb 26, 2026 | -- | -0.79 | -0.73 | $56.2M | $57.3M |
| Nov 4, 2025 | -- | -0.72 | -0.82 | $56M | $51.3M |
| Aug 5, 2025 | -- | -0.66 | -0.75 | $51.3M | $48.5M |
| May 7, 2025 | -- | -0.69 | Below forecast↓-0.81 | $43.3M | $32.7M |
| Feb 26, 2025 | -- | -0.69 | -0.72 | $38.5M | $41.8M |
| Nov 5, 2024 | -- | -0.80 | -0.73 | $35.9M | $33.3M |
| Aug 6, 2024 | -- | -0.70 | Above forecast↑-0.55 | $28.8M | $29.1M |
| May 7, 2024 | -- | -2.34 | -2.35 | $28.8M | $26M |
| Feb 22, 2024 | -- | -0.70 | -0.70 | $25.4M | $24.2M |
| Nov 7, 2023 | -- | -0.76 | -0.76 | $26.4M | $22.5M |
| Aug 1, 2023 | -- | -0.80 | -0.82 | $23M | $19.2M |
| May 2, 2023 | -- | -0.71 | Below forecast↓-0.92 | $12.1M | $11.5M |
| Mar 1, 2023 | -- | -0.82 | -0.75 | $7.2M | $8.8M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-04 ↗
Earnings Release8-K · 2026-08-04 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-02-26 ↗
Earnings Release8-K · 2026-02-26 ↗
Quarterly10-Q · 2025-11-04 ↗
Earnings Release8-K · 2025-11-04 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
